𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantification of angiogenesis stimulators in children with solid malignancies

✍ Scribed by Helena Pavlakovic; Volker Von Schütz; Jochen Rössler; Ewa Koscielniak; Werner Havers; Lothar Schweigerer

Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
112 KB
Volume
92
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B19 parvovirus infection in children wit
B19 parvovirus infection in children with malignant solid tumors receiving chemotherapy
✍ Rao, Sreedhar P. ;Miller, Scott T. ;Cohen, Bernard J. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

## Abstract Two children with rhabdomyosarcoma developed severe anemia following chemotherapy; anemia was more severe compared to that observed following earlier chemotherapy cycles. While one patient had a brisk reticulocytosis, the other had no demonstrable reticulocytes. Both patients had eviden

Phase I trial of subcutaneous interleuki
Phase I trial of subcutaneous interleukin-1α in children with malignant solid tumors
✍ Furman, Wayne L.; Luo, Xiaolong; Fairclough, Diane; Garrison, Leslie; Marina, Ne 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Interleukin-1 alpha (IL-1 alpha) is myeloprotective in a variety of animal models of cancer chemotherapy and is similarly beneficial in adults treated with carboplatin, 5-fluorouracil, and after autologous bone marrow transplantation. There are no trials of this agent in children. Our purpose was to

Recombinant human erythropoietin for the
Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors
✍ León, Pedro; Jiménez, Miguel; Barona, Pascual; Sierrasesúmaga, Luis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Background. Cancer is often associated with chronic anemia which frequently requires blood transfusions. This study was performed to assess the efficacy and safety of r-HuEPO therapy in children with cancer. Patients and methods. Twenty-five patients under 18 years of age with solid malignant